Ultragenyx Pharmaceutical RARE SEC Filings

NASDAQ RARE
$15.92 -0.10 (-0.62%)
At close: Oct 21, 2026 · 4:00 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Ultragenyx Pharmaceutical Inc. (RARE) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
1SCHEDULE 13GBeneficial Ownership Report0001013594-26-001062Oct 20, 2026 1:37 AM
24Insider Transaction0001193125-26-425032Oct 19, 2026 9:48 PM
38-KCurrent Report0001193125-26-424739Oct 19, 2026 5:00 PM
48-KCurrent Report0001193125-26-421079Oct 14, 2026 5:00 PM
58-KCurrent Report0001193125-26-416251Oct 7, 2026 9:00 AM
68-KCurrent Report0001515673-26-000006Sep 17, 2026 7:55 PM
74Insider Transaction0001193125-26-392233Sep 15, 2026 10:57 PM
8144Insider Transaction0001950047-26-009497Sep 15, 2026 8:33 PM
94Insider Transaction0001193125-26-384878Sep 8, 2026 4:29 PM
108-KCurrent Report0001193125-26-380165Sep 2, 2026 4:04 PM
118-KCurrent Report0001193125-26-357185Aug 19, 2026 9:24 PM
128-KCurrent Report0001193125-26-343525Aug 11, 2026 8:30 AM
13SCHEDULE 13GBeneficial Ownership Report0000093751-26-000549Aug 7, 2026 3:05 PM
1410-QQuarterly & Annual Report0001193125-26-333233Aug 5, 2026 10:07 PM
154Insider Transaction0001193125-26-332547Aug 4, 2026 7:15 PM
164Insider Transaction0001193125-26-332536Aug 4, 2026 7:13 PM
178-KCurrent Report0001193125-26-332802Aug 4, 2026 4:09 PM
18144Insider Transaction0001950047-26-007510Aug 3, 2026 8:18 PM
19SCHEDULE 13GBeneficial Ownership Report0002100121-26-001001Jul 31, 2026 3:40 PM
20SCHEDULE 13GBeneficial Ownership Report0002100119-26-001487Jul 31, 2026 2:46 PM
21SCHEDULE 13GBeneficial Ownership Report0002012383-26-003116Jul 30, 2026 3:18 PM
224Insider Transaction0001193125-26-296128Jul 6, 2026 7:37 PM
23144Insider Transaction0001950047-26-006703Jul 1, 2026 8:19 PM
244Insider Transaction0001796536-26-000007Jun 15, 2026 10:50 PM
254Insider Transaction0001677455-26-000002Jun 15, 2026 10:46 PM
26144Insider Transaction0001950047-26-006115Jun 15, 2026 8:50 PM
27144Insider Transaction0001950047-26-006073Jun 15, 2026 8:12 PM
28S-8Prospectus0001193125-26-269040Jun 12, 2026 1:40 PM
294Insider Transaction0001786335-26-000002Jun 1, 2026 11:11 PM
30144Insider Transaction0001950047-26-005347Jun 1, 2026 8:08 PM
314Insider Transaction0001397266-26-000002May 18, 2026 6:50 PM
324Insider Transaction0001713070-26-000002May 18, 2026 6:41 PM
334Insider Transaction0001924797-26-000002May 18, 2026 6:39 PM
344Insider Transaction0001796536-26-000004May 18, 2026 6:38 PM
354Insider Transaction0001380022-26-000002May 18, 2026 6:35 PM
364Insider Transaction0001193125-26-229224May 18, 2026 6:23 PM
374Insider Transaction0001193125-26-229222May 18, 2026 6:21 PM
38144Insider Transaction0001950047-26-004713May 18, 2026 4:50 PM
398-KCurrent Report0001193125-26-228639May 18, 2026 2:15 PM
40SCHEDULE 13GBeneficial Ownership Report0000093751-26-000302May 12, 2026 4:12 PM
414Insider Transaction0001193125-26-208632May 6, 2026 6:51 PM
424Insider Transaction0001193125-26-208632May 6, 2026 6:51 PM
4310-QQuarterly & Annual Report0001193125-26-206960May 6, 2026 10:18 PM
448-KCurrent Report0001193125-26-206368May 5, 2026 8:06 PM
454Insider Transaction0001193125-26-204402May 4, 2026 9:35 PM
464Insider Transaction0001193125-26-204402May 4, 2026 9:35 PM
474Insider Transaction0001193125-26-204402May 4, 2026 9:35 PM
48144Insider Transaction0001950047-26-003887May 1, 2026 8:06 PM
49DEFA14AOthers0001515673-26-000004Apr 30, 2026 4:04 PM
50SCHEDULE 13GBeneficial Ownership Report0002100121-26-000786Apr 29, 2026 7:48 PM
...

Ultragenyx Pharmaceutical Inc. SEC Filings API

Pull Ultragenyx Pharmaceutical Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=RARE&formtype=10-K,10-Q&api_key=YOUR_API_KEY